Overview

Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011)

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
To study retreatment in patients who failed prior treatment with interferon alpha (pegylated or non-pegylated) with or without ribavirin in a real-life setting in an observational/noninterventional study.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ribavirin